Skip to search formSkip to main contentSkip to account menu

DU127090

Known as: DU-127090 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

bifeprunox

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Review
2003
Review
2003
DU-127090 Solvay/H Lundbeck.
DU-127090 is a mixed dopamine antagonist/serotonin agonist in development by Solvay and H Lundbeck as a potential treatment for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)